Data-driven SDM to Reduce Symptom Burden in AF

StatusCompleted
PhaseNot applicable
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Results posted: Oct 15, 2026 Show 4 more changesShow less
    • Primary endpoints: 3 to 4
    • Eligibility criteria expanded, about 10 words
    • Secondary endpoints revised (2)
    • Publications: details revised at 1 of 1 entry
  2. Trial status: Active, Not Recruiting to Completed
    • Study completion date changed from estimate of Dec 31, 2025 to Aug 20, 2025
    v10
  3. Primary completion date changed from estimate of Aug 1, 2025 to Jun 20, 2025v9
  4. Trial status: Recruiting to Active, Not Recruiting
    • Primary completion date: Apr 2025 to Aug 1, 2025
    • Study completion date: Jul 2025 to Dec 31, 2025
    • Site details revised at 2 of 2 sites
    v8
  5. Primary completion date: Jan 2025 to Apr 2025v7
Show 5 earlier versionsHide 5 earlier versions
  1. Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Mar 2024 to Mar 25, 2024
    • Site details revised at 2 of 2 sites
    v6
  2. Start date: Oct 2023 to Mar 2024v5
  3. Start date: Nov 2022 to Oct 2023v4
  4. Start date: Sep 2022 to Nov 2022
    • Site contacts updated at 1 of 2 sites
    v3
  5. Lead sponsor: Weill Medical College of Cornell University to Columbia Universityv2 Show 5 more changesShow less
    • Study sites: 1 to 2
    • Start date: Aug 2022 to Sep 2022
    • Eligibility criteria expanded, about 10 words
    • Study description shortened, about 550 words
    • Study title shortened, about 2 words
  1. Study First Submitted
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This study is a single-group feasibility study evaluating decision aid visualizations which display common post-ablation symptom patterns as a tool for shared decision-making. The specific aim of the clinical trial is to evaluate the feasibility of putting the visualizations into clinical practice (n=75). The hypothesis is that patients will report low decisional conflict and decision regret and high satisfaction with their decision about whether to undergo an ablation or not.
Trial Details
NCT Number NCT04993807
Lead Sponsor Columbia University
Collaborators: National Institute of Nursing Research (NINR)
Conditions
(from sponsor)		 Atrial Fibrillation, Patient Engagement
Related terms Atrial Fibrillation, Patient Participation
Enrollment 75 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov